Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00148408 · ClinicalTrials.gov registry record · Phase 4
Trial of Asthma Patient Education (TAPE)
A Phase 4 study, sponsored by American Lung Association Asthma Clinical Research Centers.
- Completed
- Registry status
- Phase 4
- Development phase
- 600
- Enrollment target
NCT00148408: Completed Phase 4 study, sponsored by American Lung Association Asthma Clinical Research Centers.
NCT00148408 is a Phase 4 study that has completed, run by American Lung Association Asthma Clinical Research Centers. The registered enrollment target is 600 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00148408, a Phase 4 study, has completed, sponsored by American Lung Association Asthma Clinical Research Centers.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 600 participants
- Enrollment target
Study Summary
The purpose of this research study is to investigate the way that educational approaches and presentation of a drug may affect the response to montelukast and placebo (an inactive medication) in subjects with asthma.
Interventions
- DRUG Montelukast
- BEHAVIORAL Education
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 600 participants |
| Start Date | 2003-12 |
| Est. Completion | 2005-12 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00148408
The ClinicalTrials.gov registry entry for NCT00148408 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 600 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is American Lung Association Asthma Clinical Research Centers, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Montelukast is the first listed.
NCT00148408 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00148408 about?
NCT00148408 is a clinical study titled "Trial of Asthma Patient Education (TAPE)". The purpose of this research study is to investigate the way that educational approaches and presentation of a drug may affect the response to montelukast and placebo (an inactive medication) in subjects with asthma.
What is the current status of trial NCT00148408?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 600 participants. The study started on 2003-12. Estimated completion is 2005-12.
What interventions are being tested in trial NCT00148408?
The interventions under investigation include: Montelukast (DRUG), Education (BEHAVIORAL).
Who is sponsoring clinical trial NCT00148408?
This trial is sponsored by American Lung Association Asthma Clinical Research Centers, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.